Literature DB >> 33602051

Evaluation of the High Resolution Melting Approach for Detection of β-Thalassemia Gene Mutations.

Amna Tariq1,2, Sana Khurshid1, Muhammad Sajjad3.   

Abstract

β-Thalassemia (β-thal), an autosomal recessive hemoglobinopathy, is one of the most common genetic disorders in Pakistan. Awareness of this disease, genetic counseling, extended family carrier screening and prenatal diagnosis (PND) are helpful in prevention and control. Currently, direct DNA sequencing and multiple amplification refractory mutation system-polymerase chain reaction (MARMS-PCR) are the methods used to detect β-thal mutations, the latter being the most widely used. This study aimed to evaluate PCR-high resolution melting (PCR-HRM) analysis for the detection of most common β-thal mutations that are found in Pakistan. This study was designed to identify the β-thal mutations using PCR-HRM analysis in a total of 90 samples [blood and chorionic villus sampling (CVS)]. These samples were first screened for routine mutations by MARMS-PCR and then evaluated by PCR-HRM analysis. The results of PCR-HRM analyses were further confirmed by direct DNA sequencing and all analyses interpreted the same results in all 90 samples. Eleven cases (36.6%) were detected to carry IVS-I-5 (G>C) (HBB: c0.92 + 5G>C), six cases (20.0%) with frameshift codons (FSC) 41/42 (-TTCT) (HBB: c.126_129delCTTT), five cases (16.0%) were diagnosed with codon 15 (G>A) (HBB: c.47G>A), three cases (10.0%) were found with codon 30 (G>C) (HBB: c.93G>C), one case was diagnosed with FSC 16 (-C) (HBB: c.51delC), one with IVS-I-1 (G>T) (HBB: c0.92 + 1G>T) and one with codon 5 (-CT) (HBB: c.17_18delCT). The PCR-HRM analysis represents a less tedious and more useful method for the detection of β-globin gene mutations.

Entities:  

Keywords:  PCR-high resolution melting (PCR-HRM) analysis; chorionic villus sampling (CVS); multiple amplification refractory mutation system-polymerase chain reaction (MARMS-PCR); β-Thalassemia (β-thal)

Mesh:

Substances:

Year:  2021        PMID: 33602051     DOI: 10.1080/03630269.2020.1867566

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  1 in total

1.  Molecular classification of blood and bleeding disorder genes.

Authors:  Batoul Baz; Mohamed Abouelhoda; Dorota Monies; Tarek Owaidah; Majed Dasouki; Nada Al Tassan
Journal:  NPJ Genom Med       Date:  2021-07-16       Impact factor: 8.617

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.